We developed a PCOS mouse model in pubertal female mice using treatment with the aromatase inhibitor, letrozole, to limit the conversion of testosterone to estrogen which results in increased testosterone and decreased estrogen levels. Here, CYP19A1 is linked to polycystic ovary syndrome.